Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 1
2000 5
2002 5
2003 6
2004 10
2005 4
2006 10
2007 10
2008 13
2009 6
2010 10
2011 7
2012 18
2013 12
2014 10
2015 7
2016 10
2017 10
2018 2
2019 10
2020 24
2021 23
2022 22
2023 23
2024 21
2025 23
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.
Gonzalez-Kozlova E, Sweeney R, Figueiredo I, Tuballes K, Ozbey S, Hamon P, Park MD, Ioannou G, Nose Y, Guo R, Restrepo P, Buckup M, Roudko V, Hennequin C, Le Berichel J, Venturini N, Halasz L, Troncoso L, Tabachnikova A, Chang C, Reid A, Brown H, Chin T, Cabal R, Mattiuz R, Eikawa S, Del Valle DM, Gonsalves TR, LaMarche NM, Jamal H, Lansky A, Yi N, Nelson D, Morgenroth-Rebin J, Merand R, Villagomez B, D'Souza D, Radkevich E, Nie K, Chen Z, Tada Y, Nishikawa H, Ward SC, Fiel MI, Brody R, Tabrizian P, Gunasekaran G, Kamphorst AO, Cohen N, Curotto de Lafaille M, Hapanowicz O, Lucas N, Wu K, James N, Lin JC, Thurston G, Schwartz M, Fiaschi N, Kim-Schulze S, Merad M, Marron TU, Gnjatic S. Gonzalez-Kozlova E, et al. Among authors: gnjatic s. Nat Med. 2026 Jan 27. doi: 10.1038/s41591-025-04177-6. Online ahead of print. Nat Med. 2026. PMID: 41593194
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.
Pilcher WC, Yao L, Gonzalez-Kozlova E, Pita-Juarez Y, Karagkouni D, Acharya CR, Michaud ME, Hamilton M, Nanda S, Song Y, Sato K, Wang JT, Satpathy S, Ma Y, Schulman J, D'Souza D, Jayasinghe RG, Ohlstrom D, Ferguson KE, Cheloni G, Bakhtiari M, Pabustan N, Nie K, Foltz JA, Saldarriaga I, Alaaeldin R, Lepisto E, Chen R, Fiala MA, Thomas BE, Cook A, Santos JVD, I-Ling C, Figueiredo I, Fortier J, Slade M, Oh ST, Rettig MP, Anderson E, Li Y, Dasari S, Strausbauch MA, Simon VA; Immune Atlas Consortium; Radkevich E, Rahman AH, Chen Z, Lagana A, DiPersio JF, Rosenblatt J, Kim-Schulze S, Lonial S, Kumar S, Bhasin SS, Kourelis T, Dhodapkar MV, Vij R, Avigan D, Cho HJ, Mulligan G, Ding L, Gnjatic S, Vlachos IS, Bhasin M. Pilcher WC, et al. Among authors: gnjatic s. Nat Cancer. 2026 Jan;7(1):224-246. doi: 10.1038/s43018-025-01072-4. Epub 2026 Jan 9. Nat Cancer. 2026. PMID: 41514053 Free PMC article.
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).
Sater S, Bifulco CB, Rodriguez-Canales J, Yeong J, Akturk G, Angelo M, Ballesteros-Merino C, Bankhead P, Basu S, Blando JM, Brajkovic S, Cassano M, Chen BJ, Coskun AF, Cottrell TR, De Andrea CE, Edwards RH, Egelston C, Engle LL, Ernstoff MS, Fan R, Feldman M, Fox BA, Galon J, Gartrell R, Gnjatic S, Green BF, Gulley JL MD,, Hellebust A, Hewitt S, Hollmann TJ, Horn LA, Howat WJ, Hoyt CC, Jensen SM, Kulasinghe A, Lassoued W, Lott S, Mansfield J, Marwitz S, Netto G, Page DB, Parra E, Rimm DL, Rodig SJ, Salgado R, Schapiro D, Schalper KA MD,, Sunshine JC, Surace MJ, Szalay AS, Thurin M, Villasboas JC, Wharton K, Wistuba II, Yearley JH, Yuan Y, Zaki G, Ziai J, Taube JM. Sater S, et al. Among authors: gnjatic s. J Immunother Cancer. 2025 Dec 21;13(12):e012280. doi: 10.1136/jitc-2025-012280. J Immunother Cancer. 2025. PMID: 41423269 Free PMC article.
Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy.
Barcena-Varela M, Shang J, Mogno I, Lozano A, Liebling I, Mead KR, Li Z, Grinspan LT, Lindblad KE, Ruiz de Galarreta M, Donne R, Gnjatic S, Merad M, Jun T, Ang C, Marron TU, Faith J, Lujambio A. Barcena-Varela M, et al. Among authors: gnjatic s. bioRxiv [Preprint]. 2025 Dec 12:2025.12.09.693238. doi: 10.64898/2025.12.09.693238. bioRxiv. 2025. PMID: 41415394 Free PMC article. Preprint.
Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myeloma.
Ohlstrom DJ, Pilcher WC, Michaud ME, Acharya C, Satpathy S, Gonzalez-Kozlova E, Jayasinghe RG, Ferguson K, Mumme HL, Nanda S, Song Y, Mantrala S, Karagkouni D, Schulman J, Pabustan N, Vieira Dos Santos J, Sherbenou DW, Keats JJ, Gout AM, Foltz S, Lagana A, Kourelis T, Vij R, Dhodapkar MV, Avigan D, Cho HJ, Baughn LB, Nooka AK, Lonial S, Kumar S, Samur MK, Vlachos IS, Ding L, Gnjatic S, Mulligan G, Bhasin MK. Ohlstrom DJ, et al. Among authors: gnjatic s. Blood Cancer Discov. 2025 Dec 9. doi: 10.1158/2643-3230.BCD-25-0205. Online ahead of print. Blood Cancer Discov. 2025. PMID: 41364805
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma.
Wen PY, Manzanera A, Duault C, Gonzalez-Kozlova E, Lopez L, Grossman SA, Ye X, Fisher J, Lee I, Walbert T, Snyder J, Brem S, Desai A, Bagley SJ, Kakani C, Strowd R, Tatter S, Laxton A, Lesser G, Amankulor N, Lieberman F, Drappatz J, Mantica M, Triggs D, Haymaker C, Wistuba II, Al-Atrash G, Mendoza Perez J, Futreal A, Little LD, Islam MDH, Duose D, Jiang P, Reuben A, Lawler SE, Pichavant M, Gentles A, Bendall S, Kong A, Camacho C, Del Valle D, Kim-Schulze S, Gnjatic S, Sharon E, Nowicki MO, Peruzzi P, Lane D, Aguilar-Cordova E, Aguilar LK, Nichols G, Dwyer J, Tak PP, Maecker H, Barone F, Chiocca EA. Wen PY, et al. Among authors: gnjatic s. Neuro Oncol. 2025 Oct 1;27(10):2617-2631. doi: 10.1093/neuonc/noaf079. Neuro Oncol. 2025. PMID: 40120123 Clinical Trial.
A single-cell spatial transcriptomic census of human skin anatomy.
Restrepo P, Wilder A, Houser A, Ramirez A, Hren MG, Gill R, Kazmi A, Chen L, Demircioglu D, Hasson D, Soto A, McQuillan S, Gonzalez-Kozlova E, Brody R, Ungar B, Kasper M, Torina P, Lewin JM, Gnjatic S, Ma S, Ji AL. Restrepo P, et al. Among authors: gnjatic s. bioRxiv [Preprint]. 2025 Sep 23:2025.09.22.676865. doi: 10.1101/2025.09.22.676865. bioRxiv. 2025. PMID: 41040330 Free PMC article. Preprint.
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS).
Rini BI, Best AF, Bowman MD, Mishkin GE, Denicoff AM, Rubinstein LV, Harris L, Geiger AM, Mark NM, Pergam SA, Warner JL, Khorana AA, Gnjatic S, Yen TWF, Liles DK, Bestvina CM, Shah NJ, Norrell JT, Hershman DL, Holter-Chakrabarty JL, Poklepovic AS, Chanock SJ, Sankaran H, Korde LA. Rini BI, et al. Among authors: gnjatic s. JAMA Oncol. 2025 Sep 1;11(9):990-998. doi: 10.1001/jamaoncol.2025.2010. JAMA Oncol. 2025. PMID: 40674082 Free PMC article.
Multiparametric cellular and spatial organization in cancer tissue lesions with a streamlined pipeline.
Buckup M, Figueiredo I, Ioannou G, Ozbey S, Cabal R, Tabachnikova A, Troncoso L, Le Berichel J, Zhao Z, Ward SC, Hennequin C, Akturk G, Hamel S, Fiel MI, Brody R, Schwartz M, Marron TU, Kim-Schulze S, Roudko V, Gonzalez-Kozlova E, Hamon P, Merad M, Gnjatic S. Buckup M, et al. Among authors: gnjatic s. Nat Biomed Eng. 2025 Aug 25. doi: 10.1038/s41551-025-01475-9. Online ahead of print. Nat Biomed Eng. 2025. PMID: 40855123
Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients.
Trivieri MG, Devesa A, Robson PM, Bose S, Cangut B, Liao S, Kaufman A, Pyzik R, Fauveau V, Wood J, Shpiner A, Yoo E, Huang S, Calcagno C, Mani V, Thapi S, Contreras J, Nie K, Kim-Schulze S, Gnjatic S, Merad M, Ghesani M, Putrino D, Jacobi A, Mancini D, Powell C, Fayad ZA. Trivieri MG, et al. Among authors: gnjatic s. J Nucl Med. 2025 Jul 1;66(7):1126-1134. doi: 10.2967/jnumed.124.268980. J Nucl Med. 2025. PMID: 40306969
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.
Patel SP, Fisher J, Chae YK, Soto LS, Kasi A, Konda B, Walshauser M, Parra E, Zhang J, Duault C, Gonzalez-Kozlova E, Manyam G, Zhang J, Chen H, Duose DY, Laberiano Fernandez C, Luthra R, Al-Atrash G, Kim-Schulze S, Maecker HT, Wistuba II, Gnjatic S, Lee JJ, Zhang J, Magner CM, Chen HX, Sharon E, Othus M, Ryan CW, Blanke C, Haymaker CL, Kurzrock R. Patel SP, et al. Among authors: gnjatic s. J Immunother Cancer. 2025 Jun 30;13(6):e011760. doi: 10.1136/jitc-2025-011760. J Immunother Cancer. 2025. PMID: 40588371 Free PMC article. Clinical Trial.
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.
Monette A, Aguilar-Mahecha A, Altinmakas E, Angelos MG, Assad N, Batist G, Bommareddy PK, Bonilla DL, Borchers CH, Church SE, Ciliberto G, Cogdill AP, Fattore L, Hacohen N, Haris M, Lacasse V, Lie WR, Mehta A, Ruella M, Sater S, Spatz A, Taouli B, Tarhoni I, Gonzalez-Kozlova E, Tirosh I, Wang X, Gnjatic S. Monette A, et al. Among authors: gnjatic s. Clin Cancer Res. 2025 Jun 13;31(12):2278-2293. doi: 10.1158/1078-0432.CCR-24-3791. Clin Cancer Res. 2025. PMID: 40197626 Review.
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma.
Cappuyns S, Piqué-Gili M, Esteban-Fabró R, Philips G, Balaseviciute U, Pinyol R, Gris-Oliver A, Vandecaveye V, Abril-Fornaguera J, Montironi C, Bassaganyas L, Peix J, Zeitlhoefler M, Mesropian A, Huguet-Pradell J, Haber PK, Figueiredo I, Ioannou G, Gonzalez-Kozlova E, D'Alessio A, Mohr R, Meyer T, Lachenmayer A, Marquardt JU, Reeves HL, Edeline J, Finkelmeier F, Trojan J, Galle PR, Foerster F, Mínguez B, Montal R, Gnjatic S, Pinato DJ, Heikenwalder M, Verslype C, Van Cutsem E, Lambrechts D, Villanueva A, Dekervel J, Llovet JM. Cappuyns S, et al. Among authors: gnjatic s. J Hepatol. 2025 Jun;82(6):1036-1049. doi: 10.1016/j.jhep.2024.12.016. Epub 2024 Dec 19. J Hepatol. 2025. PMID: 39709141 Free PMC article.
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.
Saxena M, Marron TU, Kodysh J, Finnigan JP Jr, Onkar S, Kaminska A, Tuballes K, Guo R, Sabado RL, Meseck M, O'Donnell TJ, Sebra RP, Parekh S, Galsky MD, Blasquez A, Gimenez G, Bicak M, Cimen Bozkus C, Delbeau-Zagelbaum D, Rodriguez D, Acuna-Villaorduna A, Misiukiewicz KJ, Posner MR, Miles BA, Irie HY, Tiersten A, Doroshow DB, Wolf A, Mandeli J, Brody R, Salazar AM, Gnjatic S, Hammerbacher J, Schadt E, Friedlander P, Rubinsteyn A, Bhardwaj N. Saxena M, et al. Among authors: gnjatic s. Cancer Discov. 2025 May 2;15(5):930-947. doi: 10.1158/2159-8290.CD-24-0934. Cancer Discov. 2025. PMID: 40094414 Clinical Trial.
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.
Galsky MD, Kockx M, Roels J, Van Elzen R, Guan X, Yuen K, Rishipathak D, Anker JF, Gnjatic S, Izadmehr S, Sanjabi S, Johnston RJ, Peterson M, Koeppen H, David JM, Gupta S, Bamias A, Arranz JA, Kikuchi E, De Santis M, Davis ID, Williams P, Bernhard S, Mellman I, Grande E, Banchereau R, Mariathasan S. Galsky MD, et al. Among authors: gnjatic s. Cancer Immunol Res. 2025 Apr 2;13(4):476-486. doi: 10.1158/2326-6066.CIR-24-0649. Cancer Immunol Res. 2025. PMID: 39853278 Free PMC article.
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.
Cottrell TR, Lotze MT, Ali A, Bifulco CB, Capitini CM, Chow LQM, Cillo AR, Collyar D, Cope L, Deutsch JS, Dubrovsky G, Gnjatic S, Goh D, Halabi S, Kohanbash G, Maecker HT, Maleki Vareki S, Mullin S, Seliger B, Taube J, Vos W, Yeong J, Anderson KG, Bruno TC, Chiuzan C, Diaz-Padilla I, Garrett-Mayer E, Glitza Oliva IC, Grandi P, Hill EG, Hobbs BP, Najjar YG, Pettit Nassi P, Simons VH, Subudhi SK, Sullivan RJ, Takimoto CH. Cottrell TR, et al. Among authors: gnjatic s. J Immunother Cancer. 2025 Mar 7;13(3):e010928. doi: 10.1136/jitc-2024-010928. J Immunother Cancer. 2025. PMID: 40054999 Free PMC article.
Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data.
Yoo SK, Fitzgerald CW, Cho BA, Fitzgerald BG, Han C, Koh ES, Pandey A, Sfreddo H, Crowley F, Korostin MR, Debnath N, Leyfman Y, Valero C, Lee M, Vos JL, Lee AS, Zhao K, Lam S, Olumuyide E, Kuo F, Wilson EA, Hamon P, Hennequin C, Saffern M, Vuong L, Hakimi AA, Brown B, Merad M, Gnjatic S, Bhardwaj N, Galsky MD, Schadt EE, Samstein RM, Marron TU, Gönen M, Morris LGT, Chowell D. Yoo SK, et al. Among authors: gnjatic s. Nat Med. 2025 Mar;31(3):869-880. doi: 10.1038/s41591-024-03398-5. Epub 2025 Jan 6. Nat Med. 2025. PMID: 39762425 Free PMC article.
287 results